Your browser doesn't support javascript.
loading
Individual analysis of patients with HoFH participating in a phase 3 trial with lomitapide: The Italian cohort.
Averna, M; Cefalù, A B; Stefanutti, C; Di Giacomo, S; Sirtori, C R; Vigna, G.
Affiliation
  • Averna M; Università di Palermo, Italy. Electronic address: maurizio.averna@unipa.it.
  • Cefalù AB; Università di Palermo, Italy.
  • Stefanutti C; 'Sapienza' University of Rome, Italy.
  • Di Giacomo S; 'Sapienza' University of Rome, Italy.
  • Sirtori CR; Università di Milano, Center for Dyslipidemias, Niguarda Hospital, Milano, Italy.
  • Vigna G; Università di Ferrara, Ferrara, Italy.
Nutr Metab Cardiovasc Dis ; 26(1): 36-44, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26723464

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Receptors, LDL / Heterozygote / Hyperlipoproteinemia Type II / Anticholesteremic Agents / Mutation Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nutr Metab Cardiovasc Dis Journal subject: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Year: 2016 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Receptors, LDL / Heterozygote / Hyperlipoproteinemia Type II / Anticholesteremic Agents / Mutation Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Nutr Metab Cardiovasc Dis Journal subject: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Year: 2016 Document type: Article Country of publication: Netherlands